Bachem Holding AG (SWX:BANB)

Market Cap	3.93B
Revenue (ttm)	605.26M
Net Income (ttm)	120.25M
Shares Out	74.97M
EPS (ttm)	1.60
PE Ratio	32.71
Forward PE	31.00
Dividend	0.85 (1.68%)
Ex-Dividend Date	May 5, 2025

Volume	149,365
Average Volume	133,985
Open	50.15
Previous Close	50.65
Day's Range	49.90 - 52.45
52-Week Range	43.34 - 91.65
Beta	1.02
RSI	59.84
Earnings Date	Jul 24, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Chemicals
• Sector: Materials
• Founded: 1971
• Employees: 2,207
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: BANB

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.